Getting Biosimilars on the US Market
-
After having attended the seminar you will be aware of the current regulatory framework in the US and know the pitfalls you should avoid in order to launch your products on time.48.1599932 11.6200621
- MAHP Newsletter
- PhRel Newsletter
| Was |
|
|---|---|
| Wann |
25.10.2017 von 09:00 bis 17:30 |
| Veranstaltungsort | München, Leonardo Hotel Munich Arabellapark |
| Stadt | München |
| Kontaktname | Dr. Henriette Wolf-Klein |
| Kontakttelefon | +49 6221 500-680 |
| Zielgruppe |
This seminar should be of interest to all in the pharmaceutical industry involved in bringing their biosimilar products to the US market. In particular, those working in regulatory affairs, market access and legal affairs/IP will benefit from the experts' first-hand knowledge. |
| Termin übernehmen |
vCal
iCal
|
Do you intend to bring your biosimilar products to the US market? Then you should not miss out on this seminar. Three experts provide first-hand knowledge on things you should do with regard to:
-regulatory affairs; and
-legal affairs and IP.
After having attended the seminar you will be aware of the current regulatory framework in the US and know the pitfalls you should avoid in order to launch yourproducts on time.
Themen:
- Marketing authorisation approval at the FDA
- Getting ready to launch
- Prelaunch activities under the Bolar amendment
- Patent dispute resolution under the Biosimilar Act
- Practical tips for the US biosimilar applicant
Weitere Informationen über diesen Termin…
FORUM Institut für Management GmbH
Programm
1710233.pdf
—
PDF document,
240 kB (246,287 bytes)
